Full-Time

Account Manager

Confirmed live in the last 24 hours

Benchling

Benchling

501-1,000 employees

Cloud-based platform for life sciences R&D

Enterprise Software
Biotechnology

Compensation Overview

$100k - $152kAnnually

+ Commission + Total on-target earnings

Senior, Expert

San Francisco, CA, USA

This is a hybrid position, which may require some in-office days.

Category
Customer Success Management
Sales & Account Management
Required Skills
Sales

You match the following Benchling's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BS or M.Sc. in Biology, Molecular Biology, Genetics, Biotechnology, Bioengineering or similar Life Science field with 3+ years experience in Life Sciences, ideally in a lab or research setting
  • 5+ years of Account management, Customer Success, Renewal Management, Sales, Professional Services, or Consulting experience in a SaaS software environment with the ability to forge relationships with users, decision makers, and influential stakeholders
  • 3-5+ years commercial experience in negotiations utilizing skills to handle contract discussions and ensure favorable outcomes for both the customer and the company
  • An understanding of Life Sciences R&D processes and scientific concepts. Demonstrated ability to immediately interface and build trust with Scientists, as well as Director & VP Level Business and IT leaders in top Biotech and Pharma companies
  • Excellent communication skills, able to communicate confidently and concisely in verbal, written and presentation formats to all types of audiences
  • Self-motivated, independent, adaptable, and can thrive in a fast-paced startup environment
  • Ability to travel 10-20% based on customer needs
Responsibilities
  • Build and maintain productive relationships with key stakeholders across Scientific and IT functional areas including customer champions and economic buyers
  • Experience managing complex customers with highly technical implementations
  • Define and implement customer engagement models throughout the lifetime customer journey to ensure customer satisfaction, governance, expansion opportunity in order to maximize value.
  • Ensure strong processes and systems are in place so that trends in customer contraction and churn are identified early, communicated with the appropriate audience, and appropriate follow-up action is taken
  • Manage the renewal experience, identify and define client challenges or new scientific business case opportunities aligned with the customers’ objectives and vision with support from the extended Benchling team to client success and avoid contraction/churn.
  • Experience negotiating large renewals and expansions in collaboration with sales to drive accurate forecasting around adoption, expansion and retention.

Benchling provides a platform designed for life sciences research and development, primarily catering to biotech and pharmaceutical companies, academic institutions, and research organizations. Its cloud-based platform includes tools like an electronic lab notebook, molecular biology tools, and sample tracking systems, which help scientists manage experimental data, collaborate with colleagues, and streamline workflows. Users can design experiments, record results, and analyze data in an organized way. Benchling operates on a subscription-based model, offering various pricing tiers based on organizational size and feature needs, ensuring a steady revenue stream. The company differentiates itself by providing tailored enterprise solutions and additional services like training and support, aiming to enhance the efficiency of scientific research and accelerate the development of innovations in the life sciences sector.

Company Size

501-1,000

Company Stage

Series F

Total Funding

$400.7M

Headquarters

San Francisco, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Benchling's acquisition of PipeBio enhances AI-powered antibody discovery capabilities.
  • Partnerships with companies like Sanofi accelerate digital transformation in pharmaceutical R&D.
  • Growing demand for cloud-based solutions boosts Benchling's market potential.

What critics are saying

  • Emerging biotech software platforms could erode Benchling's market share.
  • Rapid AI advancements may require significant investment to maintain competitiveness.
  • Data privacy concerns could undermine trust in Benchling's platform.

What makes Benchling unique

  • Benchling offers a comprehensive cloud-based platform for life sciences R&D.
  • The platform integrates AI and machine learning for advanced research capabilities.
  • Benchling's tools facilitate collaboration and data sharing across global scientific teams.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Four months of fully paid parental leave

401(k) plan

Remote working stipend

Yearly company-wide retreat

Monthly gym and wellness stipend

Commuter benefits

100% premiums covered for health, dental, and vision

Weekly company social events

Flexible PTO and company-wide winter holiday shutdown

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

1%
Benchling
Oct 23rd, 2024
Benchling acquires PipeBio to accelerate AI-powered antibody discovery

We’re excited to announce Benchling’s acquisition of PipeBio, a leader in high-throughput bioinformatics analysis, to drive biologics discovery.

ArcticStartup
Oct 22nd, 2024
Danish startup joins US-based Benchling, aiming to revolutionize antibody discovery

The collaboration is expected to improve the efficiency of the discovery process by combining PipeBio's advanced sequence analysis tools with Benchling's established software ecosystem.

SynBioBeta
Oct 10th, 2024
Novonesis Teams Up with Benchling to Supercharge Biosolutions R&D

In a significant move to streamline its R&D operations, Novonesis, a global leader in biosolutions, has selected Benchling as its digital platform to enhance the discovery, development, and testing processes across its scientific teams.

Cradle Bio
Sep 25th, 2024
We Welcome Sam Partovi as Our Chief Commercial Officer

Under his leadership, Benchling expanded its customer base to over 1,000 companies, including more than 20 of the top 50 global biopharma companies and hundreds of emerging, growth, and enterprise biotechnology firms.

Worldtempus
Sep 1st, 2024
Could This Be the Funkiest Watch at Geneva Watch Days?

With heaps of creativity and now a new collaboration with H. Moser & Cie., Benc is starting to leave his "underdog" status behind.

Tech.eu
Jun 12th, 2024
Sanofi forms cloud partnership with Benchling

Sanofi forms cloud partnership with Benchling.

Tech.eu
Jun 12th, 2024
Sanofi Forms Cloud Partnership With Benchling

R&D Cloud provider Benchling Sanofi , which will use its cloud services has partnered with French global pharmaceutical company across more than 1,500 scientists from 30 teams.Benchling software that powers many biotech startups and more than half of the top 50 global biopharma companies. Over 200,000 scientists rely on the Benchling R&D Cloud as their central source of truth for scientific data, analysis and collaboration.Sanofi is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.Benchling is working with Sanofi to transition from legacy R&D systems to a digital platform through Benchling R&D Cloud; this is an integral process to enable Sanofi's AI-powered R&D ambition. As a result of the partnership, its R&D teams are able to scale and accelerate groundbreaking research processes in just hours instead of weeks.Benchling R&D Cloud is used by teams across Sanofi, including early discovery-omics such as precision oncology, core therapeutic pipeline teams including novel modalities like mRNA, all the way up the lifecycle to translational teams. Through Benchling's R&D Cloud, complex data from various departments at Sanofi is aggregated, enabling better decision-making, analytics, and collaboration. This real-time visibility into standardized data across teams gives Sanofi high-quality inputs to gain new insight faster."Sanofi is paving the way for a new era of biotechnology, where every stage of R&D is faster, smarter, and more automated," said Sajith Wickramasekara, CEO and co-founder Benchling

PR Newswire
Jun 11th, 2024
Benchling Builds Digital Data Foundation Powering Sanofi Ai-Driven Rd

Over 30 global teams and 1,500 scientists at Sanofi use Benchling for R&D data capture and analysisSAN FRANCISCO, June 11, 2024 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 scientists from 30 teams.Benchling is working with Sanofi to transition from legacy R&D systems to a digital platform through Benchling R&D Cloud; this is an integral process to enable Sanofi's AI-powered R&D ambition. As a result of Sanofi's digital and AI leadership, R&D teams are able to scale and accelerate groundbreaking research processes in just hours instead of weeks."Sanofi is paving the way for a new era of biotechnology, where every stage of R&D is faster, smarter, and more automated," said Sajith Wickramasekara, CEO and co-founder Benchling. "Sanofi's adoption of Benchling unlocks their ability to harness AI. With our R&D Cloud, Sanofi scientists can do their best work and accelerate timelines for life-changing medicines."Benchling R&D Cloud is used by teams across Sanofi, including early discovery-omics such as precision oncology, core therapeutic pipeline teams including novel modalities like mRNA, all the way up the lifecycle to translational teams. Through Benchling's R&D Cloud, complex data from various departments at Sanofi is aggregated, enabling better decision-making, analytics, and collaboration. This real-time visibility into standardized data across teams gives Sanofi high-quality inputs to gain new insight faster.About BenchlingBenchling creates the software that powers the biotechnology industry, serving cutting-edge start-ups and more than half of the top 50 global biopharma companies

PharmiWeb
Apr 30th, 2024
Zealand Pharma Partners With Benchling To Advance R&D Of Engineered Peptide Medicines

San Francisco, USA Zurich, Switzerland. April 23, 2024. Today Benchling announced that Zealand Pharma A/S, (“Zealand”) a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling RD Cloud as its central source of truth for scientific data, collaboration, and insights. Teams across Zealand will use the Benchling RD Cloud to capture, analyze, and share stability data internally and with their external contract manufacturing organization (CMO) partners, in compliance with GxP. “Our research progresses quickly, every action needs to be traceable and verifiable. Scientists and partners can’t be slowed down by siloed systems or a lack of consistent data,” said Ludo Otterbein, Head of IT at Zealand Pharma

PR Newswire
Apr 23rd, 2024
Zealand Pharma Partners With Benchling To Advance Rd Of Engineered Peptide Medicines

Fast-growing Danish biotech adopts Benchling R&D Cloud for greater data accessibility, collaboration, and complianceSAN FRANCISCO and ZURICH, April 23, 2024 /PRNewswire/ -- Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data, collaboration, and insights. Teams across Zealand will use the Benchling R&D Cloud to capture, analyze, and share stability data internally and with their external contract manufacturing organization (CMO) partners, in compliance with GxP."Our research progresses quickly, every action needs to be traceable and verifiable. Scientists and partners can't be slowed down by siloed systems or a lack of consistent data," said Ludo Otterbein, Head of IT at Zealand Pharma. "Connecting the lab and automating data capture and sharing through technology is a critical priority. Benchling will provide Zealand with the digital data foundation that helps us safely and confidently scale new use cases and partners."Zealand is a Nasdaq Copenhagen 25 (OMX C25) Index company with a mission to change lives with next generation peptide medicines, focusing on metabolic diseases such as obesity. The company works across many CMOs and partners and requires real-time access to data and secure, compliant information exchange